Optimized anti–tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule
Harald Ehrhardt(University Hospital Ulm), Irmela Jeremias(Helmholtz Zentrum München)
Cited by 32
Related Papers
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304
Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
|Molecular and Cellular Pediatrics|2016|131
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
|Blood|2022|100
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|78
Cell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis
|Cell Death and Disease|2013|45